RELEReleases

AbbVie and Galderma Dominate 80% of Aesthetic Medicine AI Citations

Two pharmaceutical giants, AbbVie and Galderma, effectively dictate the digital patient pipeline in the $25 billion aesthetic medicine industry. According to the 2026 AI Visibility Index, these companies secure 80% of all AI-generated citations, leaving thousands of independent medical spas to compete for a mere 5% of search visibility.

Bio & NewsJune 23, 20261,029 reads0

The report, issued by 5W AI Communications, analyzed how major AI engines like ChatGPT, Claude, and Google AI Overviews route potential patients to providers. The findings reveal a stark consolidation of market influence, where AbbVie/Allergan leads with 47% of citation share, followed by Galderma at 33%. Smaller competitors Merz Aesthetics and Revance manage to capture the remainder of the top-tier visibility.

This concentration of influence creates a significant "Visibility Gap" for the roughly 12,000 facilities operating nationwide. While individual brands like Botox maintain near-total dominance—scoring 95 out of 100—independent med spas and even large chains like LaserAway struggle to gain traction against pharmaceutical marketing power. The data underscores a shift in consumer behavior where AI-driven answers serve as the primary gatekeeper for medical consultations, often excluding local providers before a patient makes a single inquiry.

Comments (0)

Leave a comment

No comments yet. Be the first!